keyword
https://read.qxmd.com/read/38256915/lansoprazole-ameliorates-isoniazid-induced-liver-injury
#21
JOURNAL ARTICLE
Eri Wakai, Takashi Shiromizu, Shota Otaki, Junko Koiwa, Satoshi Tamaru, Yuhei Nishimura
Isoniazid is a first-line drug in antitubercular therapy. Isoniazid is one of the most commonly used drugs that can cause liver injury or acute liver failure, leading to death or emergency liver transplantation. Therapeutic approaches for the prevention of isoniazid-induced liver injury are yet to be established. In this study, we identified the gene expression signature for isoniazid-induced liver injury using a public transcriptome dataset, focusing on the differences in susceptibility to isoniazid in various mouse strains...
January 8, 2024: Pharmaceuticals
https://read.qxmd.com/read/38231298/trend-analysis-of-proton-pump-inhibitor-consumption-and-expenditure-the-real-world-evidence
#22
JOURNAL ARTICLE
Francesco Ferrara, Maurizio Capuozzo, Venere Celotto, Alessandro Ottaiano, Roberto Langella, Andrea Zovi
INTRODUCTION: Proton pump inhibitors (PPIs) constitute a widely utilized pharmaceutical class, frequently associated with notable instances of therapeutic inappropriateness. Such patterns of misuse not only contribute to elevated healthcare expenditure, but may also exacerbate clinical conditions in certain patients. METHODS: A comprehensive analysis was conducted between 2019 and 2023 to assess all prescriptions dispensed using the Anatomical, Therapeutic and Chemical (ATC) classification system, which allowed trends among primary PPIs to be visualized...
January 17, 2024: Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology
https://read.qxmd.com/read/38213955/omeprazole-induced-rapid-drug-reaction-with-eosinophilia-systemic-symptoms-and-cross-reactivity-in-delayed-type-hypersensitivity-associated-with-proton-pump-inhibitors-a-case-report-and-literature-review
#23
Kanokkarn Pinyopornpanish, Kanokporn Pinyopornpanish, Kanokwan Pinyopornpanish, Juthipong Benjanuwattra, Putthapon Teepapan, Apinya Chungcharoenpanich, Wannada Laisuan
BACKGROUND: Omeprazole, a proton pump inhibitor (PPI), is a widely used and generally safe agent for treating acid-related gastrointestinal conditions. However, drug reaction with eosinophilia and systemic symptoms (DRESSs) syndrome has been reported. OBJECTIVES: To report a case of omeprazole-induced rapid DRESS syndrome and to review the literature. METHODS: Descriptive analysis of one new case and a case series from literature review. RESULTS: We report a case of 82-year-old woman presenting with rapid-onset of DRESS syndrome...
2024: Case Reports in Immunology
https://read.qxmd.com/read/38142444/prescribing-patterns-of-proton-pump-inhibitors-in-germany-a-retrospective-study-including-472%C3%A2-146-patients
#24
JOURNAL ARTICLE
Kate Plehhova, Monika Haering, Joshua Wray, Cathal Coyle, Eduardo Ibáñez, Karel Kostev
The aims of this study were to analyze proton pump inhibitor (PPI) users in Germany, defining and classifying them in terms of treatment appropriateness, and to analyze the PPI prescription practices of healthcare providers. The updated DGVS (Deutsche Gesellschaft für Gastroenterologie, Verdauungs-und Stoffwechselkrankheiten) gastroesophageal reflux disease (GERD) treatment guideline (published March 2023) for mild heartburn symptoms recommends carrying out a probatory treatment of mild symptoms via other medication such as antacids, alginates, and H2 blockers before escalating to PPI treatments, if the patient profile allows...
2023: Journal of Primary Care & Community Health
https://read.qxmd.com/read/38133593/vonoprazan-voquezna-for-erosive-esophagitis
#25
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
December 25, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/38132119/unravelling-the-gastroprotective-potential-of-kefir-exploring-antioxidant-effects-in-preventing-gastric-ulcers
#26
JOURNAL ARTICLE
Larissa Zambom Côco, Rafaela Aires, Glaucimeire Rocha Carvalho, Eduarda de Souza Belisário, Michelle Khai Khun Yap, Fernanda Gobbi Amorim, Javier Conde-Aranda, Breno Valentim Nogueira, Elisardo Corral Vasquez, Thiago de Melo Costa Pereira, Bianca Prandi Campagnaro
The present study was conducted to evaluate the protective effect of milk kefir against NSAID-induced gastric ulcers. Male Swiss mice were divided into three groups: control (Vehicle; UHT milk at a dose of 0.3 mL/100 g), proton pump inhibitor (PPI; lansoprazole 30 mg/kg), and 4% milk kefir (Kefir; 0.3 mL/100 g). After 14 days of treatment, gastric ulcer was induced by oral administration of indomethacin (40 mg/kg). Reactive oxygen species (ROS), nitric oxide (NO), DNA content, cellular apoptosis, IL-10 and TNF-α levels, and myeloperoxidase (MPO) enzyme activity were determined...
December 8, 2023: Cells
https://read.qxmd.com/read/38124422/anti-inflammatory-effects-of-weiyan-i-decoction-against-gastric-ulcers-in-a-rat-model-via-inhibition-of-p38-mitogen-activated-protein-kinases-signaling
#27
JOURNAL ARTICLE
Xu Yifei, Hong Xinxin, Luo Liuru, Lin Yandan, Li Jingwei, Li Haiwen, Guo Shaoju, Huang Bin
Gastric ulcer (GU) is a common gastrointestinal disease that can lead to complications such as bleeding, perforation and even cancer. Weiyan I Decoction (WYI) is an effective Chinese medicine prescription against GU. This study aimed to explore the therapeutic mechanism of WYI in GU. WYI constituents were analyzed via ultra-high-performance liquid chromatography-mass spectrometry. SD rats were divided into control, model, lansoprazole (30mg/kg), SB203580 (2mg/kg), WYI (10.8g/kg, 5.4g/kg and 2.7g/kg) groups...
November 2023: Pakistan Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38072775/exploring-the-impact-of-ethnicity-on-drug-pharmacokinetics-using-pbpk-models-a-case-study-with-lansoprazole-in-japanese-subjects
#28
JOURNAL ARTICLE
Udoamaka Ezuruike, Liam Curry, Oliver Hatley, Iain Gardner
AIM: To demonstrate the use of PBPK modelling to explore the impact of ethnic differences on drug PK. METHOD: A PBPK model developed for lansoprazole was used to predict the clinical PK of lansoprazole in Japanese subjects by incorporating the physiological parameters of a Japanese population into the model. Further verification of the developed Japanese population with clinical studies involving eight other CYP substrates- omeprazole, ticlopidine, alprazolam, midazolam, nifedipine, cinacalcet, paroxetine and dextromethorphan was also carried out...
December 10, 2023: British Journal of Clinical Pharmacology
https://read.qxmd.com/read/38049205/acid-suppressive-drugs-a-systematic-review-and-network-meta-analysis-of-their-nocturnal-acid-inhibitory-effect
#29
JOURNAL ARTICLE
Shupeng Zou, Mengling Ouyang, Qian Cheng, Xuan Shi, Minghui Sun
BACKGROUND AND AIMS: Acid-suppressive drugs (ASDs) are widely used in many gastric acid-associated diseases. Nocturnal acid breakthrough has been a common problem of many ASDs, such as proton-pump inhibitors (PPIs) and H2 -receptor antagonists (H2RAs). Potassium-competitive acid blockers (P-CABs) are expected to solve this continuing conundrum. This article examined major ASDs and compared them with placebo in terms of nocturnal acid-inhibitory effects, using a network meta-analysis of randomized controlled trials (RCTs)...
December 4, 2023: Pharmacotherapy
https://read.qxmd.com/read/38016383/protective-effect-of-amauroderma-rugosum-ethanol-extract-and-its-primary-bioactive-compound-ergosterol-against-acute-gastric-ulcers-based-on-lxr-mediated-gastric-mucus-secretions
#30
JOURNAL ARTICLE
Yifei Xu, Linsun Lin, Huantian Zheng, Siyuan Xu, Xinxin Hong, Tiantian Cai, Jianqu Xu, Weijian Zhang, Yanzhen Mai, Jingwei Li, Bin Huang, Zhu Liu, Shaoju Guo
BACKGROUND: Amauroderma rugosum (Blume & T. Nees) Torrend (Ganodermataceae) is an edible mushroom with a wide range of medicinal values. Our previous publication demonstrated the therapeutic effects of the water extract of A. rugosum (WEA) against gastric ulcers. However, the protective effects of the ethanol extract of A. rugosum (EEA) on gastric mucosa and its major active constituents have not yet been elucidated. PURPOSE: This study aims to evaluate the gastroprotective effects and underlying mechanisms of EEA and its fat-soluble constituent, ergosterol, in acute gastric ulcers...
November 22, 2023: Phytomedicine
https://read.qxmd.com/read/38003303/novel-peritoneal-sclerosis-rat-model-developed-by-administration-of-bleomycin-and-lansoprazole
#31
JOURNAL ARTICLE
Kosei Kunitatsu, Yuta Yamamoto, Shota Nasu, Akira Taniji, Shuji Kawashima, Naoko Yamagishi, Takao Ito, Shigeaki Inoue, Yoshimitsu Kanai
In our preliminary experiment, peritoneal sclerosis likely induced by peritoneal dialysis was unexpectedly observed in the livers of rats given bleomycin and lansoprazole. We examined whether this peritoneal thickening around the liver was time-dependently induced by administration of both drugs. Male Wistar rats were injected with bleomycin and/or lansoprazole for 2 or 4 weeks. The 3YB-1 cell line derived from rat fibroblasts was treated by bleomycin and/or lansoprazole for 24 h. The administration of both drugs together, but not individually, thickened the peritoneal tissue around the liver...
November 9, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37999256/assessing-the-therapeutic-efficacy-of-proton-transport-inhibitors-in-a-triple-negative-breast-cancer-murine-model-with-magnetic-resonance-imaging-chemical-exchange-saturation-transfer-tumor-ph-imaging
#32
JOURNAL ARTICLE
Chetan Dhakan, Annasofia Anemone, Vittoria Ventura, Antonella Carella, Alessia Corrado, Elisa Pirotta, Daisy Villano, Feriel Romdhane, Francesco Gammaraccio, Silvio Aime, Dario Livio Longo
Proton transporters play a key role in maintaining the acidic tumor microenvironment; hence, their inhibition has been proposed as a new therapeutic treatment, although few methods can accurately assess their effect in vivo. In this study, we investigated whether MRI-CEST (Magnetic Resonance Imaging-Chemical Exchange Saturation Transfer) tumor pH imaging can be a useful tool to evaluate in vivo the therapeutic efficacy of several Proton Pump Inhibitors (PPIs) in breast cancer. Cell viability and extracellular pH assays were carried out in breast cancer cells cultured at physiological pH (7...
November 18, 2023: Metabolites
https://read.qxmd.com/read/37992805/a-simple-assay-for-inhibitors-of-mycobacterial-oxidative-phosphorylation
#33
JOURNAL ARTICLE
Serena A Harden, Gautier M Courbon, Yingke Liang, Angelina S Kim, John L Rubinstein
Oxidative phosphorylation, the combined activities of the electron transport chain (ETC) and adenosine triphosphate (ATP) synthase, has emerged as a valuable target for antibiotics to treat infection with Mycobacterium tuberculosis and related pathogens. In oxidative phosphorylation, the ETC establishes a transmembrane electrochemical proton gradient that powers ATP synthesis. Monitoring oxidative phosphorylation with luciferase-based detection of ATP synthesis or measurement of oxygen consumption can be technically challenging and expensive...
November 20, 2023: Journal of Biological Chemistry
https://read.qxmd.com/read/37989907/lansoprazole-inhibits-the-development-of-sessile-serrated-lesions-by-inducing-g1-arrest-via-skp2-p27-signaling-pathway
#34
JOURNAL ARTICLE
Tomoyuki Kawaguchi, Koichi Okamoto, Shota Fujimoto, Masahiro Bando, Hironori Wada, Hiroshi Miyamoto, Yasushi Sato, Naoki Muguruma, Katsuhisa Horimoto, Tetsuji Takayama
BACKGROUND: Although the serrated-neoplasia pathway reportedly accounts for 15-30% of colorectal cancer (CRC), no studies on chemoprevention of sessile serrated lesions (SSLs) have been reported. We searched for effective compounds comprehensively from a large series of compounds by employing Connectivity Map (CMAP) analysis of SSL-specific gene expression profiles coupled with in vitro screening using SSL patient-derived organoids (PDOs), and validated their efficacy using a xenograft mouse model of SSL...
November 22, 2023: Journal of Gastroenterology
https://read.qxmd.com/read/37987314/enzymatic-synthesis-of-pharmacologically-relevant-chiral-sulfoxides-by-improved-cb-bvmo-variants
#35
JOURNAL ARTICLE
Chen Zhao, Feng Liu, Min Zhou, Qiang Geng, Hui-Lei Yu
Baeyer-Villiger monooxygenases (BVMOs) are able to catalyse the asymmetric oxidation of sulfides. This property has made them attractive catalysts for the synthesis of chiral sulfoxide drugs. Here, we have designed and synthesised an exhaustive combinatorial mutant library of the previously identified lansoprazole sulfide monooxygenase Cb BVMOV1 . From this synthetic combinatorial mutant library, the best mutant, Cb BVMOV3 , was selected with a specific activity of approximately 1 U mg-1 for lansoprazole sulfoxides...
November 21, 2023: Chemical Communications: Chem Comm
https://read.qxmd.com/read/37961012/a-pharmacovigilance-study-of-association-between-proton-pump-inhibitors-and-rhabdomyolysis-event-based-on-faers-database
#36
JOURNAL ARTICLE
Yuxuan Sun, Ailin Zhang, Meiling Zuo, Jingtao Chen, Liqin Zhu
BACKGROUND AND AIM: The association between proton-pump inhibitors (PPIs) and rhabdomyolysis were unclear. The aim of this study was to explore and systematically analyze the potential link between five PPIs and the rhabdomyolysis events using the FDA Adverse Event Reporting System (FAERS) database. METHODS: Suspected rhabdomyolysis events associated with PPIs were identified by data mining with the reporting odds ratio (ROR), proportional reporting ratio (PRR), the information component (IC), and Empirical Bayes Geometric Mean (EBGM)...
November 14, 2023: Journal of Gastroenterology and Hepatology
https://read.qxmd.com/read/37893108/development-of-a-multifunctional-oral-dosage-form-via-integration-of-solid-dispersion-technology-with-a-black-seed-oil-based-self-nanoemulsifying-drug-delivery-system
#37
JOURNAL ARTICLE
Abdelrahman Y Sherif, Ahmad Abdul-Wahhab Shahba
Lansoprazole (LZP) is used to treat acid-related gastrointestinal disorders; however, its low aqueous solubility limits its oral absorption. Black seed oil (BSO) has gastroprotective effects, making it a promising addition to gastric treatment regimens. The present study aims to develop a stable multifunctional formulation integrating solid dispersion (SD) technology with a bioactive self-nanoemulsifying drug delivery system (SNEDDS) based on BSO to synergistically enhance LZP delivery and therapeutic effects...
October 9, 2023: Biomedicines
https://read.qxmd.com/read/37883084/ceftriaxone-and-the-risk-of-ventricular-arrhythmia-cardiac-arrest-and-death-among-patients-receiving-lansoprazole
#38
JOURNAL ARTICLE
Anthony D Bai, Amelia Wilkinson, Aws Almufleh, Mandip Rai, Fahad Razak, Amol A Verma, Siddhartha Srivastava
IMPORTANCE: The combination of ceftriaxone and lansoprazole has been shown to prolong the corrected QT interval on electrocardiogram. However, it is unknown whether this translates to clinically important patient outcomes. OBJECTIVE: To compare lansoprazole with another proton pump inhibitor (PPI) during ceftriaxone treatment in terms of risk for ventricular arrhythmia, cardiac arrest, and in-hospital mortality. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort study including adult medical inpatients receiving ceftriaxone with lansoprazole or another PPI in 13 hospitals in Ontario, Canada, was conducted from January 1, 2015, to December 31, 2021...
October 2, 2023: JAMA Network Open
https://read.qxmd.com/read/37879707/unexpected-cause-of-kounis-syndrome-hypersensitivity-reaction-to-omeprazole
#39
JOURNAL ARTICLE
Almina Erdem, Tufan Çınar, Şahhan Kılıç, Nazlı Begüm Öztürk
Kounis syndrome is a rare type of acute coronary syndrome (ACS) that occurs as a result of an allergic or anaphylactic reaction. Kounis syndrome can be induced by various medications including antibiotics, proton pump inhibitors, antihypertensive medications, corticosteroids, and antineoplastic medications. Additionally, cases of Kounis syndrome associated with lansoprazole and pantoprazole have been previously reported in the literature. In this report, we present a case of Kounis syndrome associated with omeprazole use, and discuss the need for a high index of suspicion as it is often underrecognised...
October 24, 2023: BMJ Case Reports
https://read.qxmd.com/read/37849735/infections-associated-with-clozapine-a-pharmacovigilance-study-using-vigibase-%C3%A2
#40
JOURNAL ARTICLE
Basile Chrétien, Perrine Brazo, Angélique Da Silva, Marion Sassier, Charles Dolladille, Véronique Lelong-Boulouard, Joachim Alexandre, Sophie Fedrizzi
Introduction: Clozapine is primarily reserved for treatment-resistant schizophrenia due to safety concerns associated with its use. Infections have been reported with clozapine, which may lead to elevated serum levels of the drug. However, the existing literature on this topic is limited. Therefore, we conducted a study using VigiBase® to investigate the potential over-reporting of infections associated with clozapine, to explore the presence of dose-dependency, and to investigate the underlying mechanism...
2023: Frontiers in Pharmacology
keyword
keyword
3617
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.